Vir Biotechnology lands a license agreement with Japan’s Astellas Pharma for its lead drug candidate.

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...

The average age of men who get diagnosed is 67.

There may be a "promising new strategy" in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia ...

Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S.

Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

Bayer sued rival Johnson & Johnson for launching a “false advertising campaign” based on flawed data to wrongfully promote ...

Certain prostate medications might help reduce the risk of Lewy body dementia, a specific type of dementia, a new study suggests. Photo by Adobe Stock/HealthDay News Prostate medications might help ...